Vivani Medical : 2024 Investor Presentation -March 26, 2024 at 12:01 pm EDT

Disclaimers


The following slides and any accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act...

Related Keywords

Boston ,Massachusetts ,United States ,Berkeley ,California ,Rhone Poulenc Rorer ,Richard Vosser ,Donald Dwyer ,Lisa Porter ,Truc Le ,Boston Scientific ,Nektar Therapeutics ,Company Pipeline ,Elutia Inc ,Astrazeneca ,Vivani Executive Leadership Team ,Okava Pharmaceuticals Inc ,Securities Exchange ,Development For Amylin ,Vivani Medical Inc ,Jp Morgan ,Johnson ,Device Companies ,Platform Technology ,Viacyte Inc ,Securities Act ,Securities Exchange Act ,Vivani Medical ,Annual Report ,Mendelsohn Phd ,Phd Bioengineering ,Technology Certificate ,Haas School ,Executive Positions ,Drug Device Companies ,Dance Biopharm ,Prima Biomed ,Former Chief Medical Officer ,Eiger Biopharmaceuticals ,Medical Development ,Former Director ,Global Head ,Clinical Strategy ,Former Board ,Current Board ,Former Executive Director ,Former Vivani Board ,Former Phasebio Board ,Rhone Poulenc ,Vivani Products ,Estimated Market Sizes ,Okava Pharmaceuticals ,Release Profiles ,Potential Application Can Support Portfolio ,New Drug ,